Oncolytic Virus Immunotherapy Market

Global Oncolytic Virus Immunotherapy Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027

  • Product Id: AIMR 1014 | Pages: 200 | Publish Date: Jun 2001 | Category: Healthcare

Latest research report on Oncolytic Virus Immunotherapy Market delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrates its growth trends and competitive landscape as well as the key players in the business.

Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).

North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.

This report focuses on the global Oncolytic Virus Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncolytic Virus Immunotherapy development in United States, Europe and China.

The key players covered in this study
    Merck
    Amgen
    TILT Biotherapeutics
    Oncorus
    Sorrento Therapeutics
    Shanghai Sunway Biotech

Market segment by Type, the product can be split into
    Engineering Oncolytic Viruses
    Wild-Type Oncolytic Viruses

Market segment by Application, split into
    Hospitals
    Clinics
    Ambulatory Surgical Centers

In this study, the years considered to estimate the market size of Oncolytic Virus Immunotherapy are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2021 to 2027

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Oncolytic Virus Immunotherapy status, future forecast, growth opportunity, key market and key players.
    To present the Oncolytic Virus Immunotherapy development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.


For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


report cover

Oncolytic Virus Immunotherapy Market Size, Top Manufacturers | COVID-19 Impact Analysis Update 2021 and Analysis 2019-2025

Table of Content
1. Chapter - Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter Global Oncolytic Virus Immunotherapy Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Oncolytic Virus Immunotherapy Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Oncolytic Virus Immunotherapy Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter - Global Oncolytic Virus Immunotherapy Market Overview: Quantitative Analysis
3.1. Global Oncolytic Virus Immunotherapy Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2016- 2027
3.2. Global Oncolytic Virus Immunotherapy Market Revenue Market Share (%), 2016- 2027
3.3. Global Oncolytic Virus Immunotherapy Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2016- 2027
3.4. Global Oncolytic Virus Immunotherapy Market Sales Market Share (%), 2016- 2027
4. Chapter Global Oncolytic Virus Immunotherapy Market Analysis: Segmentation By Type
5. Chapter Global Oncolytic Virus Immunotherapy Market Analysis: Segmentation By Application
6. Chapter - Global Oncolytic Virus Immunotherapy Market Analysis: By Manufacturer
6.1. Global Oncolytic Virus Immunotherapy Market Revenue (USD Million), by Manufacturer, 2016 - 2027
6.2. Global Oncolytic Virus Immunotherapy Market Share (%), by Manufacturer, 2018
6.3. Global Oncolytic Virus Immunotherapy Market Sales (Number of Units), by Manufacturer, 2016 - 2027
6.4. Global Oncolytic Virus Immunotherapy Market Share (%), by Manufacturer, 2018
6.5. Global Oncolytic Virus Immunotherapy Market Price (USD/Unit), by Manufacturer, 2016 - 2027
6.6. Global Oncolytic Virus Immunotherapy Market Revenue Growth Rate (%), by Manufacturer, 2016 2027
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter Oncolytic Virus Immunotherapy Market: Regional Analysis
7.1. North America
7.1.1. North America Oncolytic Virus Immunotherapy Market Revenue (USD Million) and Growth Rate (%), 2016 2027.
7.1.2. North America Oncolytic Virus Immunotherapy Market Revenue (USD Million) By Country, 2016 2027.
7.1.3. North America Oncolytic Virus Immunotherapy Revenue Market Share (%) By Country, 2016 2027.
7.1.4. North America Oncolytic Virus Immunotherapy Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2016 2027.
7.1.5. North America Oncolytic Virus Immunotherapy Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2016 2027.
7.1.6. North America Oncolytic Virus Immunotherapy Market Sales (Number of Units) and Growth Rate (%), 2016 2027.
7.1.7. North America Oncolytic Virus Immunotherapy Market Sales (Number of Units) By Country, 2016 2027.
7.1.8. North America Oncolytic Virus Immunotherapy Sales Market Share (%) By Country, 2016 2027.
7.1.9. North America Oncolytic Virus Immunotherapy Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2016 2027.
7.1.10. North America Oncolytic Virus Immunotherapy Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2016 2027.
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles

Global Oncolytic Virus Immunotherapy Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027

    Pricing

Delivery Timeline: 48 hrs
sales@aimarketreport.com

COVID-19
To know the impact of COVID-19 On Global Oncolytic Virus Immunotherapy Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027 Market

Request Now